ALLR - CIK 0001860657
Allarity Therapeutics, Inc. trades as ALLR. In its fiscal 2025 annual report the company posted revenue of $320.00K and net income of -$11.23M. This page tracks Allarity Therapeutics, Inc. through 388 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-15 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-11 |
| New insider ownership | 3 | 2026-05-11 |
| Major company event | 8-K | 2026-05-08 |
| Insider trade | 4 | 2026-05-07 |
| Major company event | 8-K | 2026-05-06 |
| Annual report to shareholders | ARS | 2026-04-30 |
The largest companies sharing Allarity Therapeutics, Inc.'s SEC industry classification (pharmaceutical preparations).
Allarity Therapeutics, Inc. reported revenue of $320.00K for fiscal year 2025.
In its latest fiscal year Allarity Therapeutics, Inc. reported a net loss of $11.23M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.